The insect repellent active ingredients market is anticipated to be valued $1.0 billion in 2023, with a 7.6% CAGR to reach $1.5 billion by 2028. The demand for insect repellent has been steadily increasing over the years due to several factors. One of the main drivers is the growing vector population. Insect repellents focus on controlling the infestation of mosquitoes, flies, ticks, bugs, fleas, and other organisms, which can cause adverse effects on humans. There have been rising instances of epidemics caused by pests such as cockroaches, bugs, mosquitoes, flies, and ants across the globe. To prevent such epidemics, various types of insect repellent formulations are being manufactured. The manufacturing may vary according to the type of insects targeted, formulations, active ingredients, concentration, permit requirements, and product registration.
Market Driver: Growing cases of disease outbreak.
More than 17% of all infectious diseases are vector-borne, according to a report released by the WHO in March 2020. Each year, these illnesses result in about 700,000 deaths. They may be caused by viruses, bacteria, or parasites. Life-threatening diseases like chikungunya, influenza, the H1N1 virus, Zika virus, and dengue have all been on the rise over the past ten years and are typically carried by insects. The Zika virus outbreak in the Americas in 2017 (spread by Aedes aegypti and Aedes albopictus) was the most latest outbreak caused by insect vectors.
The most harmful diseases are spread by mosquitoes. Millions of people globally contract mosquito-borne diseases including malaria and dengue each year. The need for insect repellent products has increased recently due to the spread of diseases.
Malaria is a parasitic infection transmitted by Anopheles mosquitoes. Globally, an estimated 219 million cases of malaria are reported; it results in more than 400,000 deaths annually. Most of the deaths occur in children below the age of five years.
Dengue is another deadly infection transmitted by Aedes mosquitoes. Every year, more than 3.9 billion people in over 129 countries contract dengue. The disease reportedly claims an estimated 40,000 lives every year. According to the National Vector Borne Disease Control Programme (NVBDCP) (India), in 2017, about 11,552 cases of dengue were reported in Tamil Nadu, recording a 350% increase in the number of cases compared to 2016.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=111358884
Aerosols segment of the insect repellent active ingredients market by end application is projected to witness the highest CAGR during the forecast period.
Based on end application type, the aerosols segment estimated to account for the highest growth rate. Aerosol insect repellents are widely used and highly effective forms of insect protection, providing a convenient and versatile solution for repelling a variety of biting insects. These products come in pressurized cans or containers and are designed to disperse a fine mist or spray of repellent. Aerosol insect repellents offer several advantages. Their spray format allows for easy and even application, ensuring complete coverage on exposed skin. The fine mist enables the repellent to reach difficult-to-access areas, such as clothing folds or hair. This makes aerosol repellents suitable for outdoor activities and areas with high insect populations.
Major players operating in the insect repellent active ingredients market includes Spectrum Brands Inc. (US), Reckitt Beneckiser Group Plc (UK), Henkel AG & Co KGaA (Germany), MERCK KGaA (Germany), S.C. Johnson & Son Inc. (US), Dabur (India), Godrej (India), Sawyer (US), BUGG Products, LLC (US), Coghlan’s (Canada), Vertellus (US), Sumitomo Chemical Co., Ltd (Japan), Clariant (Switzerland), Citrefine (UK), NK Chemiosys Pvt. Ltd. (India), and Shorgun Organics (India).
The Asia Pacific market is projected to contribute the largest share for the insect repellent active ingredients market.
Asia Pacific region is confronted with a significant challenge posed by vector-borne diseases, transmitted primarily by insects such as mosquitoes, ticks, and flies. These diseases, namely dengue fever, malaria, chikungunya, and Japanese encephalitis, have a profound impact on public health, resulting in substantial loss of life and economic burden. Each year, a considerable number of cases are reported across key countries in the region.
Mosquitoes, being prevalent insects in the Asia Pacific, are notorious for their role in spreading diseases like dengue fever, which affects millions of people annually. In 2021 according to the Ministry of Health and Family Welfare (MoHFW), India alone reported approximately 67,377 cases of dengue fever, indicating a rising trend in the country. Similarly, Japan faces the persistent threat of Japanese encephalitis, transmitted by mosquitoes, with thousands of cases reported each year. This is expected to drive the large market for insect repellents in the region.